Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000273498 | SCV000338215 | benign | not specified | 2015-12-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000273498 | SCV000714892 | likely benign | not specified | 2017-12-01 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000625247 | SCV000744310 | likely benign | Ehlers-Danlos syndrome progeroid type | 2017-06-28 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000625247 | SCV001118249 | benign | Ehlers-Danlos syndrome progeroid type | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001200179 | SCV001371072 | likely benign | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | B4GALT7: BS1 |
Genome Diagnostics Laboratory, |
RCV000625247 | SCV000745657 | likely benign | Ehlers-Danlos syndrome progeroid type | 2017-11-28 | no assertion criteria provided | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV001200179 | SCV001798313 | likely benign | not provided | no assertion criteria provided | clinical testing |